• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生酮饮食对非酒精性脂肪性肝病肝脂肪变性和肝线粒体代谢的影响。

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.

机构信息

Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.

Minerva Foundation Institute for Medical Research, Helsinki 00290, Finland.

出版信息

Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7347-7354. doi: 10.1073/pnas.1922344117. Epub 2020 Mar 16.

DOI:10.1073/pnas.1922344117
PMID:32179679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7132133/
Abstract

Weight loss by ketogenic diet (KD) has gained popularity in management of nonalcoholic fatty liver disease (NAFLD). KD rapidly reverses NAFLD and insulin resistance despite increasing circulating nonesterified fatty acids (NEFA), the main substrate for synthesis of intrahepatic triglycerides (IHTG). To explore the underlying mechanism, we quantified hepatic mitochondrial fluxes and their regulators in humans by using positional isotopomer NMR tracer analysis. Ten overweight/obese subjects received stable isotope infusions of: [D]glucose, [C]β-hydroxybutyrate and [3-C]lactate before and after a 6-d KD. IHTG was determined by proton magnetic resonance spectroscopy (H-MRS). The KD diet decreased IHTG by 31% in the face of a 3% decrease in body weight and decreased hepatic insulin resistance (-58%) despite an increase in NEFA concentrations (+35%). These changes were attributed to increased net hydrolysis of IHTG and partitioning of the resulting fatty acids toward ketogenesis (+232%) due to reductions in serum insulin concentrations (-53%) and hepatic citrate synthase flux (-38%), respectively. The former was attributed to decreased hepatic insulin resistance and the latter to increased hepatic mitochondrial redox state (+167%) and decreased plasma leptin (-45%) and triiodothyronine (-21%) concentrations. These data demonstrate heretofore undescribed adaptations underlying the reversal of NAFLD by KD: That is, markedly altered hepatic mitochondrial fluxes and redox state to promote ketogenesis rather than synthesis of IHTG.

摘要

生酮饮食(KD)减肥在非酒精性脂肪性肝病(NAFLD)的治疗中越来越受欢迎。KD 可迅速逆转 NAFLD 和胰岛素抵抗,尽管循环中非酯化脂肪酸(NEFA)增加,而 NEFA 是肝内甘油三酯(IHTG)合成的主要底物。为了探索潜在的机制,我们使用位置同位素标记 NMR 示踪剂分析方法定量了人类肝脏线粒体通量及其调节剂。10 名超重/肥胖受试者在接受为期 6 天 KD 前后分别接受 [D]葡萄糖、[C]β-羟基丁酸和 [3-C]乳酰的稳定同位素输注。质子磁共振波谱(H-MRS)测定 IHTG。KD 饮食降低了 31%的 IHTG,体重减轻了 3%,同时降低了肝胰岛素抵抗(-58%),尽管 NEFA 浓度增加(+35%)。这些变化归因于净水解 IHTG 的增加和由此产生的脂肪酸向酮生成的分配(+232%),这分别归因于血清胰岛素浓度降低(-53%)和肝柠檬酸合酶通量降低(-38%)。前者归因于肝胰岛素抵抗降低,后者归因于肝线粒体氧化还原状态增加(+167%)和血浆瘦素(-45%)和三碘甲状腺原氨酸(-21%)浓度降低。这些数据表明,KD 逆转 NAFLD 的背后存在以前未描述的适应性:即肝脏线粒体通量和氧化还原状态的显著改变,以促进酮生成而不是 IHTG 的合成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/b1b6066887cc/pnas.1922344117fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/fdccde6e731c/pnas.1922344117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/ef714965409f/pnas.1922344117fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/91a053101602/pnas.1922344117fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/349bbe1cd2bc/pnas.1922344117fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/9d9263dc7f00/pnas.1922344117fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/91e11bdb2163/pnas.1922344117fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/b1b6066887cc/pnas.1922344117fig07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/fdccde6e731c/pnas.1922344117fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/ef714965409f/pnas.1922344117fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/91a053101602/pnas.1922344117fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/349bbe1cd2bc/pnas.1922344117fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/9d9263dc7f00/pnas.1922344117fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/91e11bdb2163/pnas.1922344117fig06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a60d/7132133/b1b6066887cc/pnas.1922344117fig07.jpg

相似文献

1
Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.生酮饮食对非酒精性脂肪性肝病肝脂肪变性和肝线粒体代谢的影响。
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7347-7354. doi: 10.1073/pnas.1922344117. Epub 2020 Mar 16.
2
Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease.非酒精性脂肪性肝病肥胖患者中,非诺贝特和烟酸对肝内甘油三酯含量、极低密度脂蛋白动力学和胰岛素作用的影响。
J Clin Endocrinol Metab. 2010 Jun;95(6):2727-35. doi: 10.1210/jc.2009-2622. Epub 2010 Apr 6.
3
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.限制蛋氨酸摄入可防止瘦素缺乏型肥胖小鼠的肝脂肪变性进展。
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.
4
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.非酒精性脂肪性肝病肥胖男性和女性的脂肪组织及肝脏脂质动力学改变
Gastroenterology. 2008 Feb;134(2):424-31. doi: 10.1053/j.gastro.2007.11.038. Epub 2007 Nov 28.
5
Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者肝内甘油三酯含量的代谢和组织学意义。
Hepatology. 2017 Apr;65(4):1132-1144. doi: 10.1002/hep.28985. Epub 2017 Feb 25.
6
The ketogenic diet prevents steatosis and insulin resistance by reducing lipogenesis, diacylglycerol accumulation and protein kinase C activity in male rat liver.生酮饮食可通过减少脂肪生成、二酰基甘油积累和蛋白激酶 C 活性来预防雄性大鼠肝脏脂肪变性和胰岛素抵抗。
J Physiol. 2022 Sep;600(18):4137-4151. doi: 10.1113/JP283552. Epub 2022 Sep 4.
7
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.胰岛素抵抗导致非酒精性脂肪性肝病中的肝脏从头合成脂肪。
J Clin Invest. 2020 Mar 2;130(3):1453-1460. doi: 10.1172/JCI134165.
8
Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.非酒精性脂肪性肝病与超重青少年的肝脏和骨骼肌胰岛素抵抗有关。
Am J Clin Nutr. 2008 Aug;88(2):257-62. doi: 10.1093/ajcn/88.2.257.
9
Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease.胰岛素抵抗与非酒精性脂肪性肝病中的肝线粒体重构在机制上相关。
Mol Metab. 2021 Mar;45:101154. doi: 10.1016/j.molmet.2020.101154. Epub 2020 Dec 23.
10
β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.β-羟丁酸在肥胖相关的非酒精性脂肪性肝病患者中减少,并在体外显示出对骨骼肌线粒体呼吸的剂量依赖性效应。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E187-E195. doi: 10.1152/ajpendo.00058.2020. Epub 2020 May 12.

引用本文的文献

1
Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression.从毒素到治疗:环境污染物、肠道微生物群和天然化合物对非酒精性脂肪性肝病进展的影响
World J Hepatol. 2025 Aug 27;17(8):108772. doi: 10.4254/wjh.v17.i8.108772.
2
Adipocyte-specific deletion of gp130 prevents ketogenic diet-induced hepatic steatosis.脂肪细胞特异性缺失gp130可预防生酮饮食诱导的肝脂肪变性。
Hepatol Commun. 2025 Aug 26;9(9). doi: 10.1097/HC9.0000000000000782. eCollection 2025 Sep 1.
3
Effects of Soy Protein on Liver and Adipose Tissue Inflammation and Gut Microbiota in Mice Fed with Ketogenic Diets.

本文引用的文献

1
Energy restriction in obese women suggest linear reduction of hepatic fat content and time-dependent metabolic improvements.肥胖女性的能量限制表明肝内脂肪含量呈线性减少,且代谢改善具有时间依赖性。
Nutr Diabetes. 2019 Nov 4;9(1):34. doi: 10.1038/s41387-019-0100-2.
2
Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates.控释型线粒体质子载体(CRMP)可逆转代谢异常的非人灵长类动物的血脂异常和肝脂肪变性。
Sci Transl Med. 2019 Oct 2;11(512). doi: 10.1126/scitranslmed.aay0284.
3
Regulation of hepatic mitochondrial oxidation by glucose-alanine cycling during starvation in humans.
大豆蛋白对生酮饮食喂养小鼠肝脏和脂肪组织炎症及肠道微生物群的影响。
Nutrients. 2025 Jul 25;17(15):2428. doi: 10.3390/nu17152428.
4
Ketone metabolites in metabolic dysfunction-associated steatotic liver disease progression: optimizing keto-therapeutic strategies.代谢功能障碍相关脂肪性肝病进展中的酮类代谢产物:优化酮治疗策略
Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E290-E301. doi: 10.1152/ajpendo.00178.2025. Epub 2025 Jul 7.
5
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics.非酒精性脂肪性肝病中的肠道微生物群:病理生理学、诊断与治疗
World J Hepatol. 2025 Jun 27;17(6):106849. doi: 10.4254/wjh.v17.i6.106849.
6
Nutrient-Induced Changes of Liver Fat Content in Humans.营养诱导的人体肝脏脂肪含量变化
Physiol Res. 2025 Apr 30;74(2):163-174. doi: 10.33549/physiolres.935525.
7
Ketogenic Diets for Body Weight Loss: A Comparison with Other Diets.用于减肥的生酮饮食:与其他饮食的比较
Nutrients. 2025 Mar 10;17(6):965. doi: 10.3390/nu17060965.
8
Low-Carbohydrate (Ketogenic) Diet in Children with Obesity: Part 1-Diet Impact on Anthropometric Indicators and Indicators of Metabolic Syndrome and Insulin Resistance.肥胖儿童的低碳水化合物(生酮)饮食:第一部分——饮食对人体测量指标、代谢综合征指标及胰岛素抵抗的影响
Diseases. 2025 Mar 25;13(4):94. doi: 10.3390/diseases13040094.
9
Gut microbiota regulates hepatic ketogenesis and lipid accumulation in ketogenic diet-induced hyperketonemia by disrupting bile acid metabolism.肠道微生物群通过扰乱胆汁酸代谢来调节生酮饮食诱导的高酮血症中的肝脏生酮作用和脂质积累。
Gut Microbes. 2025 Dec;17(1):2496437. doi: 10.1080/19490976.2025.2496437. Epub 2025 Apr 23.
10
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025.肥胖儿童的代谢功能障碍相关脂肪性肝病(MASLD):肥胖医学协会(OMA)与专家联合观点(2025年)
Obes Pillars. 2025 Feb 1;14:100164. doi: 10.1016/j.obpill.2025.100164. eCollection 2025 Jun.
饥饿状态下葡萄糖-丙氨酸循环对人体肝线粒体氧化的调节作用。
J Clin Invest. 2019 Nov 1;129(11):4671-4675. doi: 10.1172/JCI129913.
4
Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids.人 PNPLA3-I148M 变异增加多不饱和脂肪酸在肝脏中的蓄积。
JCI Insight. 2019 Aug 22;4(16):127902. doi: 10.1172/jci.insight.127902.
5
Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.饱和脂肪比不饱和脂肪或简单糖对人体肝脏的代谢危害更大。
Diabetes Care. 2018 Aug;41(8):1732-1739. doi: 10.2337/dc18-0071. Epub 2018 May 29.
6
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans.碳水化合物限制饮食对人类肝脂肪变性的快速代谢益处的综合理解。
Cell Metab. 2018 Mar 6;27(3):559-571.e5. doi: 10.1016/j.cmet.2018.01.005. Epub 2018 Feb 15.
7
Interest in the Ketogenic Diet Grows for Weight Loss and Type 2 Diabetes.生酮饮食在减肥和2型糖尿病方面的关注度不断提高。
JAMA. 2018 Jan 16;319(3):215-217. doi: 10.1001/jama.2017.20639.
8
Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study.非酒精性脂肪性肝病(NAFLD)患者肝脂肪和肝硬度的预测因素:一项为期 11 年的前瞻性研究。
Sci Rep. 2017 Nov 6;7(1):14561. doi: 10.1038/s41598-017-14706-0.
9
Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA).通过位置同位素异构体核磁共振示踪分析(PINTA)对肝脏线粒体代谢进行无创评估。
Nat Commun. 2017 Oct 6;8(1):798. doi: 10.1038/s41467-017-01143-w.
10
Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.非酒精性脂肪性肝病作为代谢和肝脏疾病的纽带。
Cell Metab. 2018 Jan 9;27(1):22-41. doi: 10.1016/j.cmet.2017.08.002. Epub 2017 Aug 31.